Save Studies Locally
We can save your selected studies locally in your browser to enhance your experience. This data stays on your device and is not shared with us or third parties. You can clear this data at any time.
By allowing this, you consent to storing study selections locally on your device. Privacy Policy
How to NavigateConnectDistinguished InvestigatorsConferencesEducationRLT ComponentsSponsorsTrial Stats
This is an open label, prospective, trial that begins with a phase Ib safety run-in followed by a phase II expansion cohort.
Description:
Phase IB Study of Nivolumab in Combination With Radium-223 in Men With Metastatic Castration Resistant Prostate Cancer. This is an open label, prospective, trial that begins with a phase Ib safety run-in followed by a phase II expansion cohort.
Sponsor:
University of Utah
Government Study Link:
NCT04109729 - Click here to see study onClinicalTrials.gov
